These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6993663)

  • 61. T cells specific to hapten carrier but not to carrier alone assist in the production of anti-hapten and anti-carrier antibodies.
    Shimizu T; Osaka Y; Banri-Koike C; Yoshida M; Endo K; Furukawa K; Oda M; Murakami A; Ogawa S; Abe R; Azuma T
    Int Immunol; 2007 Oct; 19(10):1157-64. PubMed ID: 17881502
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Down-regulation of poison ivy/oak-induced contact sensitivity by treatment with a class II MHC binding peptide:hapten conjugate.
    Gelber C; Gemmell L; McAteer D; Homola M; Swain P; Liu A; Wilson KJ; Gefter M
    J Immunol; 1997 Mar; 158(5):2425-34. PubMed ID: 9036993
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Clonal assay for T helper cells (TH) and conditions for H-2-restricted linked cooperation between TH and hapten-primed B cells: application to the quantitation of hemocyanin or Leishmania tropica-specific TH in primed mice.
    Zubler RH; Louis JA
    J Immunol; 1981 Nov; 127(5):1924-30. PubMed ID: 7028867
    [No Abstract]   [Full Text] [Related]  

  • 64. Production of lymphocyte migration inhibition (LyMIF) and stimulatory (LyMSF) factors by T and B lymphocytes from rabbit peripheral blood stimulated with concanavalin-A.
    Skopińska E; Lukasik R
    Bull Acad Pol Sci Biol; 1980; 27(9):701-7. PubMed ID: 7004593
    [No Abstract]   [Full Text] [Related]  

  • 65. Regulation of lymphocyte activation: macrophage-dependent suppression of T lymphocyte protein synthesis.
    Varesio L; Holden HT
    J Immunol; 1980 Oct; 125(4):1694-701. PubMed ID: 6997385
    [TBL] [Abstract][Full Text] [Related]  

  • 66. In vitro primary sensitization of hapten-specific T cells by cultured human epidermal Langerhans cells--a screening predictive assay for contact sensitizers.
    Krasteva M; Peguet-Navarro J; Moulon C; Courtellemont P; Redziniak G; Schmitt D
    Clin Exp Allergy; 1996 May; 26(5):563-70. PubMed ID: 8735869
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Fresh and cultured Langerhans cells display differential capacities to activate hapten-specific T cells.
    Dai R; Grammer SF; Streilein JW
    J Immunol; 1993 Jan; 150(1):59-66. PubMed ID: 8417131
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Generation of anti-hapten T cell cytotoxicity in vivo. Relationship to contact sensitivity and the role of contrasuppression.
    Ptak W; Friedman AM; Flood PM
    Arch Immunol Ther Exp (Warsz); 1994; 42(3):185-92. PubMed ID: 7487350
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Human in vitro T cell sensitization using hapten-modified epidermal Langerhans cells.
    Moulon C; Péguet-Navarro J; Courtellemont P; Redziniak G; Schmitt D
    Adv Exp Med Biol; 1993; 329():209-12. PubMed ID: 8379372
    [No Abstract]   [Full Text] [Related]  

  • 70. In vitro immune blastogenesis during contact sensitivity in tumor-bearing mice. II. Mechanism of inhibition.
    Farrar WL; Elgert KD
    Cell Immunol; 1978 Oct; 40(2):365-75. PubMed ID: 309800
    [No Abstract]   [Full Text] [Related]  

  • 71. T lymphocyte stimulation by hapten-conjugated macrophages: a model system for the study of immunocompetent cell interactions.
    Thomas DW; Clement L; Shevach EM
    Immunol Rev; 1978; 40():181-204. PubMed ID: 381166
    [No Abstract]   [Full Text] [Related]  

  • 72. Antigen nonspecific lymphokines: an overview.
    Oppenheim JJ
    Methods Enzymol; 1985; 116():357-72. PubMed ID: 2418336
    [No Abstract]   [Full Text] [Related]  

  • 73. Different effects of cortisone on the humoral immune response to T-dependent and T-independent antigens.
    Mantzouranis E; Borel Y
    Cell Immunol; 1979 Mar; 43(1):202-8. PubMed ID: 313844
    [No Abstract]   [Full Text] [Related]  

  • 74. The distribution of hapten binding enthalpies in conventionally-raised antibody populations.
    Johnston MF; Pecht I; Sturtevant JM; Barisas BG
    Mol Immunol; 1979 Sep; 16(9):681-9. PubMed ID: 530277
    [No Abstract]   [Full Text] [Related]  

  • 75. Different affinities of mono-, di- and tri-DNP- ribonuclease A for anti-DNP antibody.
    Taniuchi S; Honjoh T; Tamoto K; Nakamura T; Koyama J
    Mol Immunol; 1981 Apr; 18(4):301-9. PubMed ID: 7300832
    [No Abstract]   [Full Text] [Related]  

  • 76. Primary in vitro sensitisation of human T cells.
    Newman W; Stoner GL; Bloom BR
    Nature; 1977 Sep; 269(5624):151-3. PubMed ID: 302915
    [No Abstract]   [Full Text] [Related]  

  • 77. New developments in immune competence testing.
    Hadden JW
    Clin Bull; 1978; 8(1):34-7. PubMed ID: 352575
    [No Abstract]   [Full Text] [Related]  

  • 78. Interferons and lymphokines.
    Neta R; Salvin SB
    Tex Rep Biol Med; 1981-1982; 41():435-42. PubMed ID: 6820576
    [No Abstract]   [Full Text] [Related]  

  • 79. [Tumor growth stimulating and inhibiting factors in carcinogenesis].
    Kochergina NI; Kosova IP
    Usp Sovrem Biol; 1981; 91(3):409-18. PubMed ID: 6457455
    [No Abstract]   [Full Text] [Related]  

  • 80. Pharmacological modification of immunoregulatory activity of lymphocytes: facts and potential.
    Polmar SH
    Surv Immunol Res; 1984; 3(4):274-9. PubMed ID: 6150532
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.